Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence
description
Transcript of Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence
![Page 1: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/1.jpg)
Enhancing Care Management of the Chronically Ill Through Medication
Management and Adherence
Harry Leider, MD, MBA, FACPEChief Medical Officer
XLHealth and Care Improvement Plus
![Page 2: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/2.jpg)
2
Background on XLHealth
• Founded in 1998 as a DM company focused on diabetes
• Participated in BIPA and MHS CMS DM demos
• In 2006, launched a Chronic Care Special (C-SNP) Needs Plan pilot in Maryland
– Traditional health plan structure, plus Part D, plus DM programs
• In 2007, withdrew from DM vendor business and launched Chronic Care Special Needs Plans in 6 states– 65,000 seniors – All have either: heart failure, diabetes, COPD, ESRD
• We now have full financial risk for each member – Averages $15,000 per member
![Page 3: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/3.jpg)
3
Leveraging medication data and use is a critical part of our business
1. Our members average 6 chronic medications
2. Medication spending is over 18% of our total medical spend
3. Providing access to key meds is a important aspect of our health plan value proposition to seniors
4. Achieving adherence with key medications drives outcomes in our DM programs
![Page 4: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/4.jpg)
4
Objectives
1. To provide an overview of how chronic care plans can use medication “benefit design” to improve enrollment and DM outcomes
2. To examine how medication utilization data can be leveraged to improve DM outcomes
3. To examine new technology-based tools for improving medication adherence
4. Questions and Discussion!
![Page 5: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/5.jpg)
5
Plan Formulary Design: Our Concept of “Tier 5” drugs
• While we do have traditional co-pays in our Part D plan• Our member have access to our “Tier 5 drugs” at zero cost through the
“donut hole”• Examples include:
– Beta-blockers (brand), TZDs, spironolactone, nsulin, diuretics, ACE
• The objective: improve access and adherence
A growing concern about shifting costs of drugs to patients and reducing access….
![Page 6: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/6.jpg)
6
The Value of Drug Utilization Data
1. To enhance patient identification
2. Basic risk stratification for DM Programs
3. More sophisticated predictive modeling
4. Targeting opportunities for care management
![Page 7: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/7.jpg)
7
The Value of Drug Utilization Data
1. Patient Identification/basic risk stratification for DM Programs• Spironolactone: severe Heart Failure• Oral Steroids in adults with COPD
![Page 8: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/8.jpg)
8
The Value of Drug Utilization Data
2. Basic Risk Stratification Principle:
Patients with chronic illness who are not on key medications have an increased risk of hospitalization and death…..
![Page 9: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/9.jpg)
9
Medication Management in Diabetes: 7-Year Outcomes
Adapted from Haffner SM, et al. N Engl J Med. 1998;339:229-234.
Relative 25% 25% 20% 20% 15% Risk
Diabetes + prior MI
Diabetes w/o prior MI
45%
14%
6%
20%
0
10
20
30
40
50
No Rx Statin HTN ASA FibrateTZD
Metformin
GlucoseControl
CV
D M
ort
alit
y
![Page 10: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/10.jpg)
10
The “Quick Hits” in Diabetes
• ASA
• Lipids
• ACE/ARBs
• BP control
• Beta-blockers in patients with prior MI
• Glycemic control in patients with HgbA1C > 9 or 10*
![Page 11: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/11.jpg)
11
Is it all about “Better Living Through Chemistry?”
• What about changing lifestyle issues?
• These issues are important BUT are very hard to change!
• Getting patients to diet, lose weight, exercise, and stop smoking after MANY years of bad habits is very difficult!
• Strategy:
– Focus first on the quick hits! (mostly medications)
– Then work on lifestyle issues
![Page 12: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/12.jpg)
12
3. Medications and Predictive Modeling
![Page 13: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/13.jpg)
13
ArchimedesTM: Predictive Model
• Based on 18 high quality diabetes outcomes studies
• Predicts 30 year risk of heart attacks, strokes, kidney failure, amputations, eye disease
• Model requires– Demographics information– Risk factors– Lifestyle issues– Some physical measurements (BP)– Some lab data (LDL, HDL, total cholesterol, alb/creat)– Meds for diabetes, hypertension, and hyperlipidemia
• You can change risk factors and see the impact on risk of a future outcome!!!
www.diabetes.org/diabetesphd/default.jsp
![Page 14: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/14.jpg)
14
Patient Profile: Harry 2
74 y.o. black male, obese, Type II DM, hypertensive (not controlled), moderately elevated lipids
![Page 15: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/15.jpg)
15
Health History
Risks in addition to demographics, BP, and Lipids
![Page 16: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/16.jpg)
16
Current Meds for DM, HTN, Lipids(insulin added to the model)
![Page 17: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/17.jpg)
17
Overview: 30 Yr. Risk of Major Health Outcomes
![Page 18: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/18.jpg)
18
Heart Attack risk (baseline): 45% over 10 years (on ACE already)
![Page 19: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/19.jpg)
19
Impact of Aggressive Lipid Management and Aspirin
Risk over 10 years reduced from 45% you 25% !!!!
![Page 20: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/20.jpg)
20
Additional Impact of Control of Moderate Hypertension
Minimal additional impact of control of moderate hypertension after ASA and lipid control
![Page 21: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/21.jpg)
21
Impact of Increased Glycemic Control
MI risk decreased further from 25% to 20% over 10 years
![Page 22: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/22.jpg)
22
Impact of smoking cessation(after other risk factors modified)
Risk of MI reduce >5% by smoking cessation even after lipid and HTN control, use of ASA and tight glycemic control
![Page 23: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/23.jpg)
23
Improving Adherence and Outcomes
• Medications are the most powerful interventions in many chronic conditions
• Two key drivers of outcomes– Putting patients on key drugs– Optimal levels of adherence
• Key barriers to adherence:– Patient’s can’t afford the medications– Failure to take the medications regularly
![Page 24: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/24.jpg)
24
Health Care Costs Negatively Impact Adherence
![Page 25: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/25.jpg)
25
Generics Can Reducing Drug Costs and Improve Adherence
![Page 26: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/26.jpg)
26
IVR Generic Switching Outreach
End of Campaign Summary
January 2008
![Page 27: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/27.jpg)
27
Goals Encourage members to switch to a generic
alternative/equivalent of the drug they have been prescribed
Targets XLHealth members who are currently taking either a
cholesterol drug or PPI
Generic Switching Outreach
![Page 28: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/28.jpg)
28
Generic Switching OutreachOutreach Process Overview
Confirm target member
Explain that there are low cost alternatives for current medications
Review specific savings with members who allow IVR to mention the name of drug they are taking
Review general savings with those members who do not allow the script to mention the names of the drug they are taking
Review the generic alternatives/equivalents for the drug the member is currently taking
Offer to transfer the member to a representative for more specific information regarding available savings
![Page 29: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/29.jpg)
29
Generic Switching Outreach
Key Outcomes:
Total Population: We received 16,105 records; 4.43% of records were scrubbed, leaving us with a Target Population of 15,391
members to reach out to. Targets Reached: We were able to reach 58% of target members. Typically, we see about 50% for a campaign with two rounds of outbound calls.
Yes to Continue: Close to our benchmark of 75%, 70% of the target members reached asked to continue with this call, showing the great interest in hearing more information about savings
Hang Up Rate: At 5%, as compared to our benchmark of 10% or less, we feel that this, once again, shows a strong member affinity
towards XLHealth and Care Improvement Plus.
![Page 30: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/30.jpg)
30
♦Simple - used successfully by Seniors with 5th Grade Education
♦ Manages 25 medications per patient and delivers education, questionnaires, behavioral prompts, reminders
♦Branching logic captures critical health information
♦Customized – Web-based individualized care plan
ImforMedix Med-eMonitor
![Page 31: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/31.jpg)
31Confidential and Proprietary
XLHealth/InforMedix/ADT Workflow Process
![Page 32: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/32.jpg)
32
Confidential and Proprietary
Remote Monitoring Process:
![Page 33: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/33.jpg)
33
Summary
• Medications play a critical role in a chronic care SNP (and in all DM programs)
• A specific opportunity in the C-SNP model is innovative benefit design to reduce co-pays and improve access
• “Driving” patients to generics is important to increase adherence and reduce costs
• Drug data can help identify and risk stratify patients for DM programs
• New technologies are showing promise for improving medication therapy and adherence
![Page 34: Enhancing Care Management of the Chronically Ill Through Medication Management and Adherence](https://reader035.fdocuments.us/reader035/viewer/2022062723/56813b53550346895da44497/html5/thumbnails/34.jpg)
34
Discussion and Questions?